Ocean Biomedical Inc (OCEA)
0.9207
-0.07
(-6.99%)
USD |
NASDAQ |
Sep 20, 16:00
0.9207
0.00 (0.00%)
After-Hours: 20:00
Ocean Biomedical Total Liabilities (Quarterly): 76.26M for Sept. 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 76.26M |
| June 30, 2023 | 29.32M |
| March 31, 2023 | 23.43M |
| December 31, 2022 | 6.614M |
| Date | Value |
|---|---|
| June 30, 2022 | 9.932M |
| September 30, 2021 | 5.262M |
| March 31, 2021 | 3.826M |
| December 31, 2020 | 2.271M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.271M
Minimum
Dec 2020
76.26M
Maximum
Sep 2023
19.61M
Average
8.273M
Median
Total Liabilities (Quarterly) Benchmarks
| CEL-SCI Corp | 15.60M |
| AIM ImmunoTech Inc | 9.613M |
| IGC Pharma Inc | 2.714M |
| NovaBay Pharmaceuticals Inc | 4.542M |
| Protalix BioTherapeutics Inc | 62.96M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.031M |
| Shareholders Equity (Quarterly) | -75.22M |